Atlas Trials

3-Dimensional Virtual Reality Modelling With Intravascular Indocyanine Green Fluorescence Mapping for Targeted Pulmonary Segmental Resection Trial

Clinical trial NCT06638125 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06638125
Sponsor
St. Joseph's Healthcare Hamilton
Status
NOT_YET_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Non Small Cell Lung Cancer
Start date
2026-12-01
Primary completion
2028-11-30
Enrollment
89

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.